DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,820,542 | +22.1% | 39,583 | +18.1% | 2.78% | +26.2% |
| Q2 2023 | $8,041,920 | -1.4% | 33,508 | +3.5% | 2.20% | -10.0% |
| Q1 2023 | $8,160,047 | +78.9% | 32,376 | +88.4% | 2.45% | +70.2% |
| Q4 2022 | $4,562,039 | +2.5% | 17,188 | -0.3% | 1.44% | +0.7% |
| Q3 2022 | $4,452,000 | +10.8% | 17,238 | +8.8% | 1.43% | +1.3% |
| Q2 2022 | $4,018,000 | -19.7% | 15,850 | -7.1% | 1.41% | -2.4% |
| Q1 2022 | $5,004,000 | -17.0% | 17,058 | -6.9% | 1.44% | -15.9% |
| Q4 2021 | $6,031,000 | +7.6% | 18,331 | -0.4% | 1.72% | -3.1% |
| Q3 2021 | $5,603,000 | -0.6% | 18,403 | -12.4% | 1.77% | -0.2% |
| Q2 2021 | $5,636,000 | +19.2% | 21,003 | 0.0% | 1.78% | +5.8% |
| Q1 2021 | $4,727,000 | -1.1% | 21,003 | -2.4% | 1.68% | -6.1% |
| Q4 2020 | $4,781,000 | -0.1% | 21,521 | -3.2% | 1.79% | -14.0% |
| Q3 2020 | $4,785,000 | +10.5% | 22,222 | -9.2% | 2.08% | -6.5% |
| Q2 2020 | $4,329,000 | +15.6% | 24,482 | -9.5% | 2.22% | -11.7% |
| Q1 2020 | $3,744,000 | -16.8% | 27,047 | -7.8% | 2.51% | +2.5% |
| Q4 2019 | $4,500,000 | -1.2% | 29,320 | -7.0% | 2.45% | -14.1% |
| Q3 2019 | $4,553,000 | -2.3% | 31,526 | -3.3% | 2.85% | -9.2% |
| Q2 2019 | $4,660,000 | -12.3% | 32,605 | -18.9% | 3.14% | -18.3% |
| Q1 2019 | $5,311,000 | +17.8% | 40,228 | -8.0% | 3.85% | -5.1% |
| Q4 2018 | $4,507,000 | -8.2% | 43,706 | -3.3% | 4.05% | +30.9% |
| Q3 2018 | $4,909,000 | -16.3% | 45,179 | -24.0% | 3.10% | -19.8% |
| Q2 2018 | $5,864,000 | +0.6% | 59,427 | -0.2% | 3.86% | -0.6% |
| Q1 2018 | $5,828,000 | +2.9% | 59,522 | -2.5% | 3.89% | -2.4% |
| Q4 2017 | $5,664,000 | – | 61,022 | – | 3.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |